What the Study Found (In Plain English)
Published in Journal of psychiatric research (2026), this randomized controlled trial evaluating human clinical outcomes investigated: Resting-state scalp electroencephalography (EEG) is a promising method for predicting patient outcomes of antidepressant treatments. Key clinical takeaway: We found that pre-treatment frontopolar beta duration was significantly correlated with depression score change, with greater degree of symptom response linked to shorter beta events at baseline.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (Journal of psychiatric research, 2026-06-15; Randomized Controlled Trial; Rigor 82/100): We found that pre-treatment frontopolar beta duration was significantly correlated with depression score change, with greater degree of symptom response linked to shorter beta events at baseline.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.